Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 14948 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 17635 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 28140 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 29526 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 30739 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 31272 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 31530 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 33013 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 33218 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 33293 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 35018 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 37534 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 38513 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 39071 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | 42371 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | PYRUVATE (CAS# 127-17-3); (M-H)- | Peak area | Severe disease |